Dr
Ravi
Kant
Dr
Ravi
Kant
ICMR-Senior Research Fellow Post-Doctoral
University of Delhi, India
LinkedIn
View profileBiography
A high-achieving Computational Biologist and Senior Research Fellow at the prestigious Indian Council of Medical Research (ICMR), associated with the renowned Dr. B.R. Ambedkar Center for Biomedical Research at the University of Delhi-India.
With a career spanning nine years, I excel in identifying novel drug targets, decoding their mechanisms of action, and designing small molecule inhibitors for cutting-edge therapeutic drugs and vaccine candidates. His expertise lies in leveraging advanced techniques such as Homology modeling, Pharmacophore generation, Molecular Docking, and MD simulations.
Awards and recognition have marked my journey, including multiple Bill & Melinda Gates Foundation Fellowships, Young Investigator Awards, Young Scientist Awards (thrice), and Outstanding Research Scholar Awards (twice). Most notably, I have recently been granted The BBSRC-UKRI International Partnership Funding by the University of Southampton.
The dynamic research portfolio spans across international borders, with a remarkable 14 international engagements in countries like the UK, United States, South Korea, Singapore, Canada, Thailand, South Africa, and Germany. My prolific work is showcased in numerous research papers and successful grant applications.
Currently spearheads research projects that have secured funding from leading Indian agencies, including the Indian Council of Medical Research and the Department of Biotechnology, Government of India. Additionally, I have garnered support from the UK through the BBSRC-UKRI International Partnership Funding.
My dedication to advancing the field of Computational Biology and my track record of research contribution make me an ideal candidate for leading-edge research and development roles in academia and industry. Research interests
Reverse Vaccinology based immuno-informatics identification & characterization of novel vaccine candidates for different pathogens
Prioritizing potential vaccine candidates based on functional annotation of hypothetical proteins
Vaccine development for pathogens of global interests (Mycobacterium tuberculosis, Mycobacterium bovis, Leishmania, Mycoplasma genitalium, Salmonella enterica, Candida albicans)
Veterinary medicine, Veterinary vaccinology & zoonotic infections
Accelerating vaccine developments by employing modern artificial intelligence & machine learning based approach
Structural Biology of Infectious Diseases & pathogens (especially Neglected Tropical Pathogens ; Leishmania, Trypanosoma cruzi )
Antimicrobial Resistance (AMR)
Bioinformatics & Computational Biology (Drug Discovery &Development)
Metal Organic Frameworks based materials as potential therapeutic formulations Projects you're working on
Phylogenetic Analysis of DRB3.2 gene in Bovines
In-silico Identification & characterization of novel drug targets and outer membrane proteins in Neisseria gonorroheae
Drug design through molecular modeling studies for exploring novel drug targets in Plasmodium falciparum to combat drug resistance Discipline
Bacteriology Bioinformatics Immunology – B-cells Immunology – T-cells Parasitology Structural biology Host species
Cattle Pigs Poultry Pathogen
Bacteria Bacteria›Mycobacteria bovis Viruses Viruses›African swine fever virus Viruses›Bovine ephemeral fever virus Viruses›Bovine viral diarrhoea Viruses›Classical swine fever virus Viruses›Coronavirus Viruses›Foot-and-mouth disease virus Viruses›Influenza virus Viruses›Respiratory syncytial virus Viruses›Retroviruses Stage of vaccine development
Antigen discovery and immunogen design